Portfolio Companies 2026 for Logos Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Logos Capital accounts for 45 tracked companies with verified cap-table data, 45 of which disclose round sizes totalling $8.6B. The median disclosed raise is $165M, and the largest is Mirador Therapeutics at $650M, ahead of Gracell Biotechnologies ($520M) and Neumora Therapeutics ($500M).
The names that recur most often on these portfolio cap tables are Logos Capital (45 companies), Janus Henderson Investors (20 companies), Surveyor Capital (18 companies), Cormorant Asset Management (17 companies), RA Capital Management (16 companies), OrbiMed (13 companies). By latest disclosed round, the market skews Series B (15), Series A (10), Series C (10), Growth (4).
Companies tracked: 45
Disclosed funding total: $8.6B across 45 companies
Median disclosed raise: $165M
Largest raise: Mirador Therapeutics — $650M
Stage mix: Series B 15 · Series A 10 · Series C 10 · Growth 4
